Structures by: John R. O.
Total: 28
C41H47IrN4O5,CH2Cl2
C41H47IrN4O5,CH2Cl2
Chemical Science (2019)
a=14.08570(10)Å b=11.99650(10)Å c=24.9643(2)Å
α=90° β=97.6750(10)° γ=90°
9-Nitro-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17N5O2
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.8951(10)Å b=20.050(2)Å c=8.6412(9)Å
α=90.00° β=90.160(4)° γ=90.00°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chloroosmium(II) chloride acetone solvate
C35H36Cl2N4O2Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.876(2)Å b=9.6263(19)Å c=17.460(4)Å
α=90.00° β=104.32(3)° γ=90.00°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol solvate
C36H43Cl2N5O4Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2485(4)Å b=12.6418(5)Å c=14.3132(5)Å
α=95.421(2)° β=108.122(2)° γ=118.054(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chlororuthenium(II) chloride diethanol water solvate
C36H45Cl2N5O5Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=10.771(2)Å b=25.040(5)Å c=13.238(3)Å
α=90.00° β=91.84(3)° γ=90.00°
(hapto^6^-p-Cymene){9-bromo-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C130H133Br4Cl8N16O3.5Os4
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.8319(5)Å b=14.1376(5)Å c=18.3912(6)Å
α=98.511(2)° β=107.338(2)° γ=102.012(2)°
(hapto^6^-p-Cymene){9-nitro-6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride ethanol water solvate
C35.9H42.95Cl2N5O4.08Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=12.2836(4)Å b=12.6756(4)Å c=14.2592(6)Å
α=95.491(2)° β=107.998(2)° γ=118.072(2)°
(hapto^6^-p-Cymene){6-[(alpha-picolyl-kappaN)imino-kappaN]-7,12- dihydroindolo[3,2-d][1]benzazepine}chloroosmium(II) chloride water solvate
C32H32.5Cl2N4O0.25Os
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=13.9580(7)Å b=14.0949(7)Å c=18.3531(9)Å
α=96.749(3)° β=108.022(3)° γ=102.050(3)°
C48H64Ir2N4O6S2,1.27(H2O),2(CH2Cl2)
C48H64Ir2N4O6S2,1.27(H2O),2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2019) 48, 40 15198-15206
a=9.7187(5)Å b=12.0086(7)Å c=13.3295(11)Å
α=85.912(6)° β=69.210(6)° γ=76.361(5)°
C8H9N2,Cl
C8H9N2,Cl
Chemical communications (Cambridge, England) (2018) 54, 73 10375-10378
a=5.5421(5)Å b=7.9319(9)Å c=9.4933(3)Å
α=82.068(6)° β=76.113(6)° γ=80.977(8)°
(hapto^6^-p-Cymene)[9-pyridin-kappaN-2-yl-(E)-methylidene)amino-kappaN-7,12- dihydroindolo[3,2-d][1]benzazepin-6(5H)-one]chlororuthenium(II) chloride acetone solvate
C35H36Cl2N4O2Ru
Journal of medicinal chemistry (2007) 50, 25 6343-6355
a=9.872(2)Å b=9.6208(19)Å c=17.434(4)Å
α=90.00° β=104.05(3)° γ=90.00°
Chlorido[2-methyl-3-(oxo-kappaO)-pyran-4-(1H)-thionato-kappaS] (hapto^6^-p-cymene)ruthenium(II)
C16H19ClO2RuS
Organometallics (2009) 28, 15 4249
a=8.3191(2)Å b=14.8407(4)Å c=12.9576(3)Å
α=90.00° β=99.7690(10)° γ=90.00°
Trans-[Dichloridotetrakis(imidazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=9.6110(3)Å b=18.9329(9)Å c=9.6818(3)Å
α=90.00° β=90.016(2)° γ=90.00°
Cis-[Dichloridotetrakis(imidazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=11.229(2)Å b=12.259(3)Å c=7.0080(14)Å
α=90.00° β=104.11(3)° γ=90.00°
Trans-[Dichloridotetrakis(benzimidazole)ruthenium(III)] chloride methanol diethyl ether solvate
C33H38Cl3N8O2Os
Inorganic Chemistry (2008) 47, 7338-7347
a=15.7469(4)Å b=13.6976(4)Å c=16.5585(5)Å
α=90.00° β=93.710(2)° γ=90.00°
Trans-[Dichloridotetrakis(indazole)ruthenium(III)]chloride methanol water solvate
C29H30Cl3N8O2Os
Inorganic Chemistry (2008) 47, 7338-7347
a=16.9910(4)Å b=11.1273(4)Å c=16.6057(4)Å
α=90.00° β=97.557(2)° γ=90.00°
Trans-[Dichloridotetrakis(pyrazole)ruthenium(III)]chloride
C12H16Cl3N8Os
Inorganic Chemistry (2008) 47, 7338-7347
a=7.9101(2)Å b=8.4109(2)Å c=14.6494(4)Å
α=102.690(2)° β=90.8860(10)° γ=110.743(2)°
6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H18N4
Inorganic Chemistry (2007) 46, 3645-3656
a=8.919(2)Å b=19.849(4)Å c=20.229(4)Å
α=90.00° β=90.00° γ=90.00°
9-Bromo-6-(alpha-picolylamino)-7,12-dihydroindolo[3,2-d][1]benzazepine
C22H17BrN4
Inorganic Chemistry (2007) 46, 3645-3656
a=11.0629(5)Å b=19.5840(9)Å c=8.6930(5)Å
α=90.00° β=94.466(3)° γ=90.00°
(OC-6-14)-Dichlorobis(dimethyl sulfoxide)(6-(E)-[alpha-picolyl- kappaN]-7,12-dihydroindolo[3,2-d][1]benzazepine]ruthenium(II) diethanol solvate
C30H42Cl2N4O4RuS2
Inorganic Chemistry (2007) 46, 3645-3656
a=15.366(3)Å b=7.5306(15)Å c=29.650(6)Å
α=90.00° β=104.11(3)° γ=90.00°
(OC-6-43)-Bis(9-bromo-6-(E)-[(alpha-picolyl-kappaN)imino-kappaN]- 7,12-dihydroindolo[3,2-d][1]benzazepine)chloro(dimethyl sulfoxide) ruthenium(II) chloride 2.8ethanol 0.2water
C51.6H55.2Br2Cl2N8O4RuS
Inorganic Chemistry (2007) 46, 3645-3656
a=12.4094(3)Å b=12.8933(3)Å c=18.5633(5)Å
α=106.807(2)° β=92.525(2)° γ=108.003(2)°
(quinolin-8-olato-kappaN^1^,kappaO^8^)(1H-indazol-1-ide-kappaN^2^) (1,2,3,4,5,6-hapto)-1-isopropyl-4-methylbenzene-osmium(II) trimethanol solvate
C29H37N3O4Os
Organometallics (2008) 27, 24 6587
a=10.4410(5)Å b=11.3821(5)Å c=13.4172(7)Å
α=90.499(3)° β=108.143(2)° γ=112.641(2)°
(quinolin-8-olate-kappaN^1^,kappaO^8^)(1H-imidazole-kappaN^3^) (1,2,3,4,5,6-hapto)-1-isopropyl-4-methylbenzene-ruthenium(II) trifluoromethanesulfonate
C23H24F3N3O4RuS
Organometallics (2008) 27, 24 6587
a=12.819(3)Å b=12.076(2)Å c=15.823(3)Å
α=90.00° β=105.74(3)° γ=90.00°
(quinolin-8-olato-kappaN^1^,kappaO^8^)-(1,2,2,3,4,5,6-hapto)-1-isopropyl- 4-methylbenzene-9-methyladenine-kappa-N^7^)osmium(II)-hexafluorophosphate
C25H27F6N6OOsP
Organometallics (2008) 27, 24 6587
a=17.261(4)Å b=10.044(2)Å c=16.238(3)Å
α=90.00° β=103.90(3)° γ=90.00°
(1H-benzimidazole-kappaN^3^)(quinolin-8-olato-kappaN^1^, kappaO^8^)(1,2,3,4,5,6-hapto)-1-isopropyl-4-methylbenzene- ruthenium(II) trifluoromethanesulfonate diethyl ether solvate
C29H31F3N3O4.5RuS
Organometallics (2008) 27, 24 6587
a=19.878(4)Å b=22.441(4)Å c=14.179(3)Å
α=90.00° β=115.89(3)° γ=90.00°
(hapto^6^-p-Cymene)[N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin- kappaN-6-yl)-N'-kappaN-(2-hydroxybenzylidene)azine]chloroosmium(II) chloride ethanol solvate
C35H37BrCl2N4O2Os
Organometallics (2007) 26, 26 6643
a=11.0920(10)Å b=11.1604(8)Å c=13.9373(11)Å
α=90.00° β=90.296(6)° γ=90.00°
(hapto^6^-p-Cymene)[N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin- kappaN-6-yl)-N'-kappaN-(2-hydroxybenzylidene)azine]chlororuthenium(II) chloride ethanol solvate
C35H37BrCl2N4O2Ru
Organometallics (2007) 26, 26 6643
a=11.0237(9)Å b=11.0373(7)Å c=13.7107(11)Å
α=90.00° β=90.076(6)° γ=90.00°
(hapto^6^-p-Cymene)[N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin- kappaN-6-yl)-N'-kappaN-(3-hydroxy-5-(hydroxymethyl)-2-methyl-pyridin- 4-yl-methylene)azine]chloroosmium(II) acetone water solvate
C77H88.2Br2Cl4N10O8.1Os2
Organometallics (2007) 26, 26 6643
a=13.1551(7)Å b=16.7459(9)Å c=19.1476(9)Å
α=81.092(3)° β=83.527(3)° γ=72.158(4)°